2026 Part the Cloud Translational Gene Targeting Challenge

Part the Cloud, a program through the Alzheimer's Association, announces a targeted challenge funding program focused on increasing early phase human trials (Phase 1 and Phase 2) of potential therapies tailored to the genetic underpinnings of Alzheimer’s disease and related dementias.

Phase 1: early stage testing prior to POC

Phase 2 or 3: efficacy studies

Funding: Phase 1 $1,00,000 total; Phase 2 $2,000,000 total 
Duration: 2-3 years

Research Authority due date: 29.7.25

LOI (required) due date: 6.8.25
Full proposal due date: 24.9.25